Current Controversies in the Prediction, Diagnosis, and Management of Cerebral Vasospasm: Where Do We Stand?

Aneurysmal subarachnoid hemorrhage occurs in approximately 30,000 persons in the United States each year. Around 30 percent of patients with aneurysmal subarachnoid hemorrhage suffer from cerebral ischemia and infarction due to cerebral vasospasm, a leading cause of treatable death and disability fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Young Lee, Scott L. Zuckerman, J. Mocco
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Neurology Research International
Online Access:http://dx.doi.org/10.1155/2013/373458
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566663227113472
author Young Lee
Scott L. Zuckerman
J. Mocco
author_facet Young Lee
Scott L. Zuckerman
J. Mocco
author_sort Young Lee
collection DOAJ
description Aneurysmal subarachnoid hemorrhage occurs in approximately 30,000 persons in the United States each year. Around 30 percent of patients with aneurysmal subarachnoid hemorrhage suffer from cerebral ischemia and infarction due to cerebral vasospasm, a leading cause of treatable death and disability following aneurysmal subarachnoid hemorrhage. Methods used to predict, diagnose, and manage vasospasm are the topic of recent active research. This paper utilizes a comprehensive review of the recent literature to address controversies surrounding these topics. Evidence regarding the effect of age, smoking, and cocaine use on the incidence and outcome of vasospasm is reviewed. The abilities of different computed tomography grading schemes to predict vasospasm in the aftermath of subarachnoid hemorrhage are presented. Additionally, the utility of different diagnostic methods for the detection and visualization of vasospasm, including transcranial Doppler ultrasonography, CT angiography, digital subtraction angiography, and CT perfusion imaging is discussed. Finally, the recent literature regarding interventions for the prophylaxis and treatment of vasospasm, including hyperdynamic therapy, albumin, calcium channel agonists, statins, magnesium sulfate, and endothelin antagonists is summarized. Recent studies regarding each topic were reviewed for consensus recommendations from the literature, which were then presented.
format Article
id doaj-art-1a3b85fa5a7b48e4b1385c8f45300f6a
institution Kabale University
issn 2090-1852
2090-1860
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Neurology Research International
spelling doaj-art-1a3b85fa5a7b48e4b1385c8f45300f6a2025-02-03T01:03:27ZengWileyNeurology Research International2090-18522090-18602013-01-01201310.1155/2013/373458373458Current Controversies in the Prediction, Diagnosis, and Management of Cerebral Vasospasm: Where Do We Stand?Young Lee0Scott L. Zuckerman1J. Mocco2Vanderbilt University School of Medicine, 1211 Medical Center Drive, Nashville, TN 37232, USADepartment of Neurological Surgery, Vanderbilt University School of Medicine, 1211 Medical Center Drive, Nashville, TN 37232, USADepartment of Neurological Surgery, Vanderbilt University School of Medicine, 1211 Medical Center Drive, Nashville, TN 37232, USAAneurysmal subarachnoid hemorrhage occurs in approximately 30,000 persons in the United States each year. Around 30 percent of patients with aneurysmal subarachnoid hemorrhage suffer from cerebral ischemia and infarction due to cerebral vasospasm, a leading cause of treatable death and disability following aneurysmal subarachnoid hemorrhage. Methods used to predict, diagnose, and manage vasospasm are the topic of recent active research. This paper utilizes a comprehensive review of the recent literature to address controversies surrounding these topics. Evidence regarding the effect of age, smoking, and cocaine use on the incidence and outcome of vasospasm is reviewed. The abilities of different computed tomography grading schemes to predict vasospasm in the aftermath of subarachnoid hemorrhage are presented. Additionally, the utility of different diagnostic methods for the detection and visualization of vasospasm, including transcranial Doppler ultrasonography, CT angiography, digital subtraction angiography, and CT perfusion imaging is discussed. Finally, the recent literature regarding interventions for the prophylaxis and treatment of vasospasm, including hyperdynamic therapy, albumin, calcium channel agonists, statins, magnesium sulfate, and endothelin antagonists is summarized. Recent studies regarding each topic were reviewed for consensus recommendations from the literature, which were then presented.http://dx.doi.org/10.1155/2013/373458
spellingShingle Young Lee
Scott L. Zuckerman
J. Mocco
Current Controversies in the Prediction, Diagnosis, and Management of Cerebral Vasospasm: Where Do We Stand?
Neurology Research International
title Current Controversies in the Prediction, Diagnosis, and Management of Cerebral Vasospasm: Where Do We Stand?
title_full Current Controversies in the Prediction, Diagnosis, and Management of Cerebral Vasospasm: Where Do We Stand?
title_fullStr Current Controversies in the Prediction, Diagnosis, and Management of Cerebral Vasospasm: Where Do We Stand?
title_full_unstemmed Current Controversies in the Prediction, Diagnosis, and Management of Cerebral Vasospasm: Where Do We Stand?
title_short Current Controversies in the Prediction, Diagnosis, and Management of Cerebral Vasospasm: Where Do We Stand?
title_sort current controversies in the prediction diagnosis and management of cerebral vasospasm where do we stand
url http://dx.doi.org/10.1155/2013/373458
work_keys_str_mv AT younglee currentcontroversiesinthepredictiondiagnosisandmanagementofcerebralvasospasmwheredowestand
AT scottlzuckerman currentcontroversiesinthepredictiondiagnosisandmanagementofcerebralvasospasmwheredowestand
AT jmocco currentcontroversiesinthepredictiondiagnosisandmanagementofcerebralvasospasmwheredowestand